Arrowhead Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Arrowhead Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ARWR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000879407
Board of directors
-
Adeoye Y. Olukotun · DirectorSince 2023
-
Backer Marianne De · DirectorSince 2023
-
Christopher Richard Anzalone · Director · Chief Executive OfficerSince 2023
-
Douglas B. Given · DirectorSince 2023
-
Hongbo Lu · DirectorSince 2024
-
Mauro Ferrari · DirectorSince 2023
-
Michael S. Perry · DirectorSince 2023
-
Victoria Vakiener · DirectorSince 2023
-
William D. Waddill · DirectorSince 2023
Chief executives
Christopher Richard Anzalone
· Chief Executive Officer
Dates unknown
Board connections
4 of this board's directors also sit on 5 other boards.
- via William D. Waddill
- via William D. Waddill
- via Adeoye Y. Olukotun
- via Backer Marianne De
- via Hongbo Lu
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 27, 2024 | Adeoye Y. Olukotun Director | Open-market sale | −2,850 | $20.00 | $57,000 |
| Dec 23, 2024 | Christopher Richard Anzalone Director, Officer (Chief Executive Officer) | Open-market sale | −12,563 | $19.59 | $246,109 |
| Dec 18, 2024 | Victoria Vakiener Director | Grant or award | +16,733 | $22.99 | $384,692 |
| Dec 18, 2024 | Adeoye Y. Olukotun Director | Grant or award | +16,733 | $22.99 | $384,692 |
| Dec 18, 2024 | William D. Waddill Director | Grant or award | +16,733 | $22.99 | $384,692 |
| Dec 18, 2024 | Mauro Ferrari Director | Grant or award | +16,733 | $22.99 | $384,692 |
| Dec 18, 2024 | Michael S. Perry Director | Grant or award | +16,733 | $22.99 | $384,692 |
| Dec 18, 2024 | Hongbo Lu Director | Grant or award | +16,733 | $22.99 | $384,692 |
| Dec 18, 2024 | Christopher Richard Anzalone Director, Officer (Chief Executive Officer) | Open-market sale | −12,653 | $20.52 | $259,640 |
| Dec 18, 2024 | Christopher Richard Anzalone Director, Officer (Chief Executive Officer) | Open-market sale | −8,260 | $21.74 | $179,572 |
| Dec 18, 2024 | Christopher Richard Anzalone Director, Officer (Chief Executive Officer) | Open-market sale | −5,799 | $22.12 | $128,274 |
| Dec 18, 2024 | Christopher Richard Anzalone Director, Officer (Chief Executive Officer) | Grant or award | +100,000 | — | — |
| Dec 17, 2024 | William D. Waddill Director | Open-market sale | −3,747 | $22.04 | $82,584 |
| Dec 17, 2024 | Douglas B. Given Director | Open-market sale | −547 | $22.04 | $12,056 |
| Dec 16, 2024 | William D. Waddill Director | Open-market sale | −3,748 | $21.90 | $82,081 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.